AAAAAA

   
Results: 1-8 |
Results: 8
Cu/Zn superoxide dismutase plays a role in angiogenesis
Authors: Marikovsky, M Nevo, N Vadai, E Harris-Cerruti, C
Citation: M. Marikovsky et al., Cu/Zn superoxide dismutase plays a role in angiogenesis, INT J CANC, 97(1), 2002, pp. 34-41
Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing
Authors: Tirosh, B Fridkin, M Tzehoval, E Vadai, E Lemonnier, FA Eisenbach, L
Citation: B. Tirosh et al., Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing, J IMMUNOTH, 23(6), 2000, pp. 622-630
Anti-tumor vaccination in heterozygous congenic F1 mice: Presentation of tumor-associated antigen by the two parental class I alleles
Authors: Carmon, L Tzehoval, E Tirosh, B el-Shami, KM Bar-Haim, E Vadai, E Feldman, M Eisenbach, L
Citation: L. Carmon et al., Anti-tumor vaccination in heterozygous congenic F1 mice: Presentation of tumor-associated antigen by the two parental class I alleles, J IMMUNOTH, 23(3), 2000, pp. 344-352
Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide
Authors: El-Shami, KM Tirosh, B Popovic, D Carmon, L Tzehoval, E Vadai, E Feldman, M Eisenbach, L
Citation: Km. El-shami et al., Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide, INT J CANC, 85(2), 2000, pp. 236-242
Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines
Authors: El-Shami, KM Tzehoval, E Vadai, E Feldman, M Eisenbach, L
Citation: Km. El-shami et al., Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines, J INTERF CY, 19(12), 1999, pp. 1391-1401
Immunogenicity of H-2K(b)-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination
Authors: Tirosh, B el-Shami, K Vaisman, N Carmon, L Bar-Haim, E Vadai, E Feldman, M Fridkin, M Eisenbach, L
Citation: B. Tirosh et al., Immunogenicity of H-2K(b)-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination, IMMUNOL LET, 70(1), 1999, pp. 21-28
MHC class I-restricted epitope spreading in the context of tumor rejectionfollowing vaccination with a single immunodominant CTL epitope
Authors: el-Shamil, K Tirosh, B Bar-Haim, E Carmon, L Vadai, E Fridkin, M Feldman, M Eisenbach, L
Citation: K. El-shamil et al., MHC class I-restricted epitope spreading in the context of tumor rejectionfollowing vaccination with a single immunodominant CTL epitope, EUR J IMMUN, 29(10), 1999, pp. 3295-3301
Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine Interleukin 12
Authors: Popovic, D El-Shami, KM Vadai, E Feldman, M Tzehoval, E Eisenbach, L
Citation: D. Popovic et al., Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine Interleukin 12, CLIN EXP M, 16(7), 1998, pp. 623-632
Risultati: 1-8 |